PLAINSBORO, N.J., May 2, 2025 /PRNewswire/ -- Today, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for an investigational ...
Morning Overview on MSN
IDEAYA-Servier eye cancer drug hits trial goal, clearing path to FDA filing
A closely watched clinical trial testing a new two-drug combination against metastatic uveal melanoma, the deadliest form of ...
MIRA trial data demonstrated a 43% response with 120mg SLK, and a 29 ppt delta vs placebo (p < 0.001) at week 12. VELA-1 met all primary and key secondary endpoints with statistical significance ...
The company is seeking clearance in additional gynecological indications to support outpatient use of its surgical robot.
Mitapivat has been approved in the US under the Pyrukynd trade name since 2022 as a treatment for haemolytic anaemia in ...
WASHINGTON — The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results